EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Mesopic microperimetry in Stargardt disease: Application and reliability

Sybren H Kootstra iD, Jeroen A A H Pas iD, Patty P A Dhooge iD, Steffen Schmitz-Valckenberg, Maurizio Battaglia Parodi, Philipp Herrmann, Frank G Holz, Andrew J Lotery, Katarina Stingl, Thomas H Wheeler-Schilling, Camiel J F Boon iD, Carel B Hoyng und 1 weitere

Acta Ophthalmologica · 2026

DOI: 10.1111/aos.70072 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Acta Ophthalmologica, 2026. Verfasst von Sybren H Kootstra und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Radboud University Medical Centre, Nijmegen, GA, The Netherlands. Hauptthemen laut MEDLINE: Macular Degeneration, Mesopic Vision, Stargardt Disease, Visual Acuity. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Union's Horizon 2020 research and innovation programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Mesopic microperimetry (mMP) is a promising functional endpoint in clinical trials for Stargardt disease type 1 (STGD1). This study evaluated the test–retest variability of mMP and influencing factors, which is essential for ensuring reliability in future STGD1 trials.

Methods

One hundred and fifteen eyes from 68 patients enrolled in the prospective, tertiary, multicentre STArgardt Remofuscin Treatment Trial (STARTT) underwent mMP testing using the macular integrity assessment (MAIA) microperimeter (CenterVue, Padova, Italy) at both the screening (first) and baseline (second) visits of the trial. Test–retest variability was assessed using Bland–Altman analyses and coefficients of repeatability (CoR). Retinal sensitivity metrics included mean sensitivity ( MS ) and pointwise sensitivity ( PWS ). Other factors including fixation stability, exam duration and learning effect were analysed.

Results

MS demonstrated the lowest variability (CoR: 3.53 dB, 95% CI: 3.07–3.99), while PWS exhibited the highest (CoR: 12.69 dB, 95% CI: 12.47–12.91). Variability decreased in sensitivity ranges from −1 to 3 dB and 16 to 32 dB and from central to peripheral regions. Test duration (Spearman's ρ = 0.609, p < 0.001) and fixation losses (Spearman's ρ = 0.284, p = 0.003) were significantly associated with increased variability. Other fixation stability metrics showed no correlation. No learning effect was observed.

Conclusions

Given its high variability, PWS should be used cautiously. MS offers lower variability but may mask localised functional changes. A parafoveal ring strategy may improve reliability but requires validation. Limiting test duration to ≤450 seconds and comprehensive operator training are recommended to minimise potential bias.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular DegenerationMesopic VisionStargardt DiseaseVisual AcuityVisual Field TestsVisual FieldsAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultFollow-Up StudiesProspective StudiesReproducibility of Results

Stichwörter der Autor:innen

perimetryretinastargardt diseasetreatment outcomevision tests

Autor:innen und Institutionen

  • Department of Ophthalmology, Radboud University Medical Centre, Nijmegen, GA, The Netherlands.
  • Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, EN, The Netherlands.
  • Department of Ophthalmology, University of Bonn, Bonn, Germany.
  • John A. Moran Eye Centre, University of Utah, Salt Lake City, Utah, USA.
  • GRADE Reading Centre, Bonn, Germany.
  • Department of Ophthalmology, Ospedale San Raffaele, Milan, Italy.

ORCID-Profile: Sybren H Kootstra, Jeroen A A H Pas, Patty P A Dhooge, Camiel J F Boon

Förderung

  • European Union's Horizon 2020 research and innovation programme

Zitieren

APA

Kootstra, S. H., Pas, J. A. A. H., Dhooge, P. P. A., Schmitz-Valckenberg, S., Parodi, M. B., Herrmann, P., Holz, F. G., Lotery, A. J., Stingl, K., Wheeler-Schilling, T. H., Boon, C. J. F., Hoyng, C. B., & Soraprazan Consortium (2026). Mesopic microperimetry in Stargardt disease: Application and reliability. Acta Ophthalmologica. https://doi.org/10.1111/aos.70072

Vancouver

Kootstra SH, Pas JAAH, Dhooge PPA, Schmitz-Valckenberg S, Parodi MB, Herrmann P, et al. Mesopic microperimetry in Stargardt disease: Application and reliability. Acta Ophthalmologica. 2026. doi:10.1111/aos.70072

BibTeX
@article{Kootstra2026,
  author = {Kootstra, Sybren H and Pas, Jeroen A A H and Dhooge, Patty P A and Schmitz-Valckenberg, Steffen and Parodi, Maurizio Battaglia and Herrmann, Philipp and Holz, Frank G and Lotery, Andrew J and Stingl, Katarina and Wheeler-Schilling, Thomas H and Boon, Camiel J F and Hoyng, Carel B and Soraprazan Consortium, Soraprazan Consortium},
  title = {Mesopic microperimetry in Stargardt disease: Application and reliability},
  journal = {Acta Ophthalmologica},
  year = {2026},
  doi = {10.1111/aos.70072}
}
Kostenlos starten →